Design of dominant negatives to bHLHZip proteins that inhibit DNA binding.
Krylov
D
D
Laboratory of Biochemistry, National Cancer Institute, National Institutes of Health Bethesda, Maryland 20892, USA.
Echlin
D R
DR
Taparowsky
E J
EJ
Vinson
C
C
D000818:Animals; D001483:Base Sequence; D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; D050976:Basic-Leucine Zipper Transcription Factors; D001665:Binding Sites; D001667:Binding, Competitive; D002471:Cell Transformation, Neoplastic; D004247:DNA / Q000235:genetics / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D019281:Dimerization; D004355:Drug Stability; D018257:Helix-Loop-Helix Motifs; D016350:Leucine Zippers; D051379:Mice; D016271:Proto-Oncogene Proteins c-myc / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D017384:Sequence Deletion; D014157:Transcription Factors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; D050976:Basic-Leucine Zipper Transcription Factors; D004268:DNA-Binding Proteins; C067850:Myc associated factor X; D016271:Proto-Oncogene Proteins c-myc; D014157:Transcription Factors; C068422:Max protein, mouse; D004247:DNA